scholarly journals Optomechatronic System For Automated Intra Cytoplasmic Sperm Injection

2015 ◽  
Vol 45 (4) ◽  
pp. 3-14
Author(s):  
Assen Shulev ◽  
Tihomir Tiankov ◽  
Detelina Ignatova ◽  
Kostadin Kostadinov ◽  
Ilia Roussev ◽  
...  

Abstract This paper presents a complex optomechatronic system for In-Vitro Fertilization (IVF), offering almost complete automation of the Intra Cytoplasmic Sperm Injection (ICSI) procedure. The compound parts and sub-systems, as well as some of the computer vision algorithms, are described below. System capabilities for ICSI have been demonstrated on infertile oocyte cells.

2015 ◽  
Vol 4 (4) ◽  
pp. 146-50
Author(s):  
Ehsan Shahverdi ◽  
Fatemeh Vahid Roodsari ◽  
Masoomeh Akhavan Saffar

Background: Assisted reproductive technologies (ART) are known as a treatment for infertility in which oocyte undergoes manipulation outside body. The aim of this study was to study the evaluation of birth defects in infants conceived through assisted reproductive technologies (ART) and compare them with naturally-conceived infants. Materials and Methods: In this retrospective study, four hundred naturally-conceived infants and 400 infants conceived by ARTs between 20 March and 20 November 2012 in Gha’em Hospital and Sheikh Hospital of Mashhad in Iran participated in this study. Infants were evaluated by a pediatrician at the time of birth, 10 days and 40 days after birth. Correlation between the use of IVF and/or ICSI methods and birth defects was evaluated. Results: Of total 800 infants (450 boys and 350 girls), half of the infants were conceived through natural pregnancy, 200(25%) through in-vitro fertilization (IVF) and 200 (25%) intra- cytoplasmic sperm injection (ICSI). In Infants conceived by IVF, 5 cases (2.5%) had a kind of birth defect just similar to those conceived by ICSI; while 4 cases had birth defects in natural pregnancy. There was no significant correlation between the use of IVF and/or ICSI methods in terms of birth defects (P=0.280).Conclusion: We found that using IVF or ICSI methods is not associated with increasing birth defects.[GMJ.2015;4(4):146-50]


2012 ◽  
Vol 65 (7-8) ◽  
pp. 315-318 ◽  
Author(s):  
Dejan Mitic ◽  
Vesna Kopitovic ◽  
Jasmina Popovic ◽  
Stevan Milatovic ◽  
Marin Basic ◽  
...  

Introduction. Infertility affects 15-17% of reproductive age couples in our country. In vitro fertilization brought revolution in treatment of this problem, bringing hope to many couples around the world for more than 3 decades. The aim of this paper was to present results and experiences of implementation of this method of treatment at the Clinic of Gynecology and Obstetrics in Nis. Material and Methods. The study included the first 402 women who had undergone in vitro fertilization program at the Clinical Center of Nis. The data were statistically analyzed by basic descriptive methods. The main outcome measures were demographic features, cause of infertility, duration of stimulation, average gonadothropine consumption, number of oocytes per aspiration and embryos transferred, mode of conception as well as clinical pregnancy and aspiration rate. Results. The two main factors were the male infertility and tubal factor inferitily, being 51.61% and 48.39%, respectively. The classical method of in vitro fertilization constituted 72.40% of all cycles, while intra cytoplasmic sperm injection method was used in 27.60% of all cycles. The average number of embryos transferred was 2.75. The cycle cancellation rate was 15.05%. The clinical pregnancy rate per embryo transfer was 35.44%; while the live birth rate per embryo transfer was 26.53%. Discussion and Conclusion. Our success rates are comparable with those in other European countries, where for in vitro fertilization the clinical pregnancy rates per aspiration and per transfer were 29.0 and 32.4%, respectively in the observed period. For intra cytoplasmic sperm injection, the corresponding rates were 29.9 and 33.0%. The main difference from the European average was the average number of transferred embryos and lower percentage rate of intra cytoplasmic sperm injection as a method of conception.


1990 ◽  
Vol 36 (10) ◽  
pp. 1774-1778 ◽  
Author(s):  
C M Thomas ◽  
R J van den Berg ◽  
M F Segers ◽  
L M Geelen ◽  
J M Hollanders ◽  
...  

Abstract A time-resolved fluoroimmunoassay (TR-FIA) for unconjugated estrogens in human urine is described. 6-Keto-17 beta-estradiol-6-(O-carboxymethyl)oxime:bovine serum albumin is immobilized onto microtiter strip wells and the coated wells are incubated with 17 beta-estradiol standard preparations or unknowns with a polyclonal antiserum to 17 beta-estradiol-16,17-monosuccinyl:albumin. The antiserum-bound estrogen is detected by incubation with a europium-labeled anti-rabbit IgG that serves as both second antibody and tracer. After the immunoreactions, the bound portion of the labeled antiserum is quantified by dissociating the Eu3+ in a fluorescence-enhancement solution and measuring its fluorescence with a time-resolved fluorometer. The detection limit of the TR-FIA is 24 pmol of 17 beta-estradiol per liter; the analytical range extends to 1.8 nmol/L. This assay is a convenient alternative to radioimmunoassay and to the automated Kober-Ittrich fluorometry of total estrogen. Its advantages include short counting times; use of nonradioactive, stable reagents, all of which are commercially available; and more nearly complete automation. We conclude that this TR-FIA, compared with the Kober-Ittrich fluorometric assay (J Endocrinol 1957; 16:49-56), provides the clinician with equivalent information during follicular development therapy as part of an in vitro fertilization program.


Sign in / Sign up

Export Citation Format

Share Document